Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.
/ Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, […]
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
Updated Phase 1 data presented at ESH-iCMLf 26thAnnual John Goldman Conference Reported cumulative MMR rate of 44% (8/18) by 24 […]
